A bispecific monoclonal antibody against methotrexate and a human tumour associated antigen augments cytotoxicity of methotrexate-carrier conjugate

British Journal of Cancer

Volumn 61, Issue 4, 1990, Pages 508-513

  Pimm, M V ^a   Robins, R A ^a   Embleton, M J ^a   Jacobs, E ^a   Markham, A J ^a   Charleston, A ^a   Baldwin, R W ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BISPECIFIC ANTIBODY; CHIMERIC ANTIBODY; METHOTREXATE; TUMOR ANTIGEN;

ARTICLE; DRUG CYTOTOXICITY; DRUG POTENTIATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR CELL;

ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, NEOPLASM; GLYCOPROTEINS; HUMAN; METHOTREXATE; SERUM ALBUMIN; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

EID: 0025237410     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1990.115     Document Type: Article

References (14)

1. AUSTIN, E. B., ROBINS, R. A., DURRANT, L. G., PRICE, M R. & BALD WIN, R. W. (1990). Human monoclonal anti-idiotypic antibody to tumour associated antibody 791T/36. Immunology (in the press)
2. BALDWIN, R. W., BYERS, V. S. & PIMM, M. W. (1988). Monoclonal antibodies and immunoconjugates for cancer treatment. In Cancer Chemotherapy and Biological Response, Pinedo, H. M., Longo, D. L. & Chabner, B. A. (eds) p. 397. Elsevier Science Publishers: Amsterdam
3. BALLANTYNE, K. C., PERKINS, A. C., PIMM, M. V. & 5 others (1988). Biodistribution of a monoclonal antibody-methrotrexate (79IT/36-MTX) in patients with colorectal cancer. Int. J. Cancer, Suppl. 2, 103
4. CORVALAN, J. R. F., SMITH, W., GORE, V. A., BRANDON, D. R. & RYDE, P. J. (1987a). Increased therapeutic effect of vinca alkaloids targeted to tumour by a hybrid-hybrid monoclonal antibody. Cancer Immunol. Immunother., 24, 138
5. CORVALAN, J. R. F., SMITH, W., GORE, C. A. & BRANDON, D. R. (1987b). Specific in vitro and in vivo drug localisation to tumour cells using a hybrid-hybrid monoclonal antibody. Cancer Immunol. Immunother., 24, 133
6. CORVALAN, J. R. F. & SMITH, W. (1987). Construction and character isation of a hybrid-hybrid monoclonal antibody recognising both carcinoembryonic antigen (CEA) and vinca alkaloids. Cancer Immunol. Immunother., 24, 127
7. EMBLETON, M. J., GUNN, B., BYERS, V. S. & BALDWIN, R. W. (1981). Antitumour reactions of monoclonal antibody against a human osteogenic sarcoma cell line. Br. J. Cancer, 43, 582
8. GARNETT, M. C., EMBLETON, M. J., JACOBS, E. & BALDWIN, R. W. (1983). Preparation and properties of a drug-carrier-antibody conjugate showing selective antibody directed cytotoxicity in vitro. Int. J. Cancer, 31, 661
9. 2 antibody for the delivery of saporin in the treatment of lymphoma. J. Immunol., 141, 3663
10. KARAWAJEW, L., MICHEEL, B., BEHRSING, O. & GAESTEL, M. (1987). Bispecific antibody-producing hybrid hybridomas selected by a fluorescence activated cell sorter. J. Immunol. Meth., 96, 265
11. MILSTEIN, C. & CUELLO, A C. (1984). Hybrid hybridomas and the production of bi-specific monoclonal antibodies. Immunol. Today, 5, 299
12. PIMM, M. V., CLEGG, J. A., GARNETT, M. C. & BALDWIN, R. W. (1988). Biodistribution and tumour localization of a methotrexate- monoclonal antibody 791T/36 conjugate in nude mice with human tumour xenografts. Int. J. Cancer, 41, 886
13. ROE, R., ROBINS, R. A., LAXTON, R. R. & BALDWIN, R. W. (1985). Kinetics of divalent monoclonal anitbody binding to tumour cell surface antigens using flow cytometry: standardization and mathematical analysis. Molec. Immunol., 22, 11
14. WEBB, K. S., WARE, J. L., PARKS, S. F., WALTHER, P. J. & PAULSON, D. F. (1985). Evidence for a novel hybrid immunotoxin recogniz ing A-chain by one antigen-combining site and a prostate- restricted antigen by the remaining antigen-combining site: poten tial for immunotherapy. Cancer Treat. Rep., 69, 663